Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Dec;227(12):3715-21.
doi: 10.1002/jcp.24098.

Mechanisms of apoptosis by the tumor suppressor Par-4

Nikhil Hebbar  1 , Chi Wang, Vivek M Rangnekar
Affiliations
Review

Mechanisms of apoptosis by the tumor suppressor Par-4

Nikhil Hebbar et al. J Cell Physiol. 2012 Dec.

Abstract

Par-4 is a pro-apoptotic, tumor suppressor protein that induces apoptosis selectively in cancer cells. Endoplasmic reticulum-stress and higher levels of protein kinase A in tumor cells confer the coveted feature of cancer selective response to extracellular and intracellular Par-4, respectively. Recent studies have shown that systemic Par-4 confers resistance to tumor growth in mice, and that tumor-resistance is transferable by bone-marrow transplantation. Moreover, recombinant Par-4 inhibits the growth of tumors in mice. As systemic Par-4 induces apoptosis via cell surface GRP78, strategies that promote GRP78 trafficking to the cell surface are expected sensitize cancer cells to circulating levels of Par-4. This review illustrates the domains and mechanisms by which Par-4 orchestrates the apoptotic process in both cell culture models and in physiological settings.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Functional domains of Par-4
Functionally active domains of Par-4 that are conserved across the human, rat and mouse species are depicted. The numbers depict their relative amino acid positions.
Figure 2
Figure 2. Putative domains of human Par-4
Putative domains of human Par-4 with functions yet to be confirmed experimentally are shown. Domains marked by ‡ are conserved across the human, mouse and rat species.
Figure 3
Figure 3. Relationship between mRNA levels of Par-4 and patient survival
(A) Oncomine anaylsis indicated increased Par-4 mRNA levels correlate with decreased survival in squamous cell lung carcinoma patients (logrank P = 0.061). Survival time in patients with lung adenocarcinoma shows no significant correlation with mRNA levels of Par-4 (logrank P = 0.94). (B) A composite of multiple data sets from Oncomine depicting 1 year survival status in patients with squamous cell carcinoma and adenocarcinoma of the lung. The colored squares represent data from different studies.
See this image and copyright information in PMC

References

    1. Azmi AS, Ahmad A, Banerjee S, Rangnekar VM, Mohammad RM, Sarkar FH. Chemoprevention of pancreatic cancer: characterization of Par-4 and its modulation by 3,3′ diindolylmethane (DIM) Pharm Res. 2008;25(9):2117–2124. - PMC - PubMed
    1. Boehrer S, Chow KU, Puccetti E, Ruthardt M, Godzisard S, Krapohl A, Schneider B, Hoelzer D, Mitrou PS, Rangnekar VM, Weidmann E. Deregulated expression of prostate apoptosis response gene-4 in less differentiated lymphocytes and inverse expressional patterns of par-4 and bcl-2 in acute lymphocytic leukemia. Hematol J. 2001;2(2):103–107. - PubMed
    1. Burikhanov R, Zhao Y, Goswami A, Qiu S, Schwarze SR, Rangnekar VM. The tumor suppressor Par-4 activates an extrinsic pathway for apoptosis. Cell. 2009;138(2):377–388. - PMC - PubMed
    1. Burz C, Berindan-Neagoe I, Balacescu O, Irimie A. Apoptosis in cancer: key molecular signaling pathways and therapy targets. Acta Oncol. 2009;48(6):811–821. - PubMed
    1. Cang S, Liu D. P-loop mutations and novel therapeutic approaches for imatinib failures in chronic myeloid leukemia. J Hematol Oncol. 2008;1:15. - PMC - PubMed

Publication types

MeSH terms

Substances